Fresenius Medford Dialysis (#1246) — Medford, Massachusetts

Fresenius Medford Dialysis (#1246) is a clinical research site located in Medford, Massachusetts, United States 02155.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Fresenius Medford Dialysis (#1246) has participated in 1 clinical trials.

Therapeutic areas: Dialysis, Cardiovascular Disease, Atherosclerosis.

Sponsors: Brigham and Women's Hospital.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fresenius Medford Dialysis (#1246)?

Fresenius Medford Dialysis (#1246) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fresenius Medford Dialysis (#1246) conducted?

Fresenius Medford Dialysis (#1246) has 1 clinical trials on record. Their work covers Dialysis, Cardiovascular Disease, Atherosclerosis.

Is Fresenius Medford Dialysis (#1246) accredited by Crixeo Health?

Fresenius Medford Dialysis (#1246) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fresenius Medford Dialysis (#1246)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.